Feasibility study for a cost-effectiveness analysis of the affordable medicines facility malaria (AMFM)
Location: Multi-country | Funded by: The Global Fund to Fight HIV/AIDS, Malaria and Tuberculosis
- To determine the technical feasibility of conducting a cost-effectiveness analysis for a multi-country financing mechanism (availability of models, explicabiltity, attributability)
- To determine the institutional feasibility of conducting a cost-effectiveness analysis for a multi-country financing mechanism (data availability, accuracy, institutional networks etc.)
- To provide a recommendation of possible comparator mechanisms and justify the feasibility of conducting a CEA.
Project description: Evaplan was contracted by the ad-hoc committee of The Global Fund to conduct a feasibility study for a cost-effectiveness analysis (CEA) for the AMFM, a multi-country financing mechanism designed to purchase quality-controlled malaria medicines at a subsidized rate. We performed a comprehensive literature review, conducted a comparative analysis of various economic modelling and in-depth interviews with stakeholders and international experts on malaria control and economics of malaria.